BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition-Reference-Cited by-同舟云学术

BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR–ABL1 kinase inhibition

Published:2011-05 Issue:7347 Volume:473 Page:384-388
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Duy Cihangir,Hurtz Christian,Shojaee Seyedmehdi,Cerchietti Leandro,Geng Huimin,Swaminathan Srividya,Klemm Lars,Kweon Soo-mi,Nahar Rahul,Braig Melanie,Park Eugene,Kim Yong-mi,Hofmann Wolf-Karsten,Herzog Sebastian,Jumaa Hassan,Koeffler H. Phillip,Yu J. Jessica,Heisterkamp Nora,Graeber Thomas G.,Wu Hong,Ye B. Hilda,Melnick Ari,Müschen Markus

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature09883.pdf

Reference45 articles.

1. Druker, B. J. et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N. Engl. J. Med. 344, 1038–1042 (2001)

2. Armstrong, S. A. et al. Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification. Cancer Cell 3, 173–183 (2003)

3. Meydan, N. et al. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 379, 645–648 (1996)

4. Shah, N. P. et al. Overriding imatinib resistance with a novel ABL kinase inhibitor. Science 305, 399–401 (2004)

5. O’Hare, T. et al. AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance. Cancer Cell 16, 401–412 (2009)

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of novel BCL6-Targeting PROTACs with effective antitumor activities against DLBCL in vitro and in vivo;European Journal of Medicinal Chemistry;2024-11

2. BCL6 is a context-dependent mediator of the glioblastoma response to irradiation therapy;International Journal of Biological Macromolecules;2024-06

3. Zinc Finger and BTB Domain-Containing 20: A Newly Emerging Player in Pathogenesis and Development of Human Cancers;Biomolecules;2024-02-04

4. A small molecule BCL6 inhibitor as chemosensitizers in acute myeloid leukemia;Biomedicine & Pharmacotherapy;2023-10

5. Targeting BCL6 in Gastrointestinal Stromal Tumor Promotes p53-Mediated Apoptosis to Enhance the Antitumor Activity of Imatinib;Cancer Research;2023-08-09